New therapeutic option for irritable bowel syndrome: Serum-derived bovine immunoglobulin

Table 3 Presentation of irritable bowel syndrome patients with mixed with alternating constipation and diarrhea

Patient No./age (yr)/gender	Primary Symptoms	Comorbidity	Other GI Therapy	SBI Therapy/Duration	Outcome
IBS-M 1/33/F	Alternating diarrhea and constipation,	Morbid obesity	Low FODMAP diet	Ongoing	Overall improvement,
	bloating, distension,			15 wk	mild obstipation,
	ABD pain				reduced bloating
IBS-M	Alternating diarrhea and constipatio, bloating, distension	Osteoporosis	Low FODMAP diet	Ongoing	No bloating or distension, improved bowel movements
2/66/F				14 wk

IBS-M: Irritable bowel syndrome with mixed with alternating constipation and diarrhea; SBI: Serum-derived bovine immunoglobulin; GI: Gastrointestinal.